GlassScriptPhysician profile
Terrie X Tran
NPI 1477695005
$10,647.45
in general payments reported to CMS, 2019-2025
9 companies · $116 in 2025
The $116 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $8.07 · 2021: $102 · 2023: $10K · 2024: $131 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $9,084 · Food and Beverage: $1,007 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $9,083.93 |
| Food and Beverage | $1,007.36 |
| Education | $287.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $9,160.03 | 2019-2025 | Invisalign, Itero |
| Dentsply Sirona INC | $967.80 | 2023 | Cerec Tessera |
| Straumann USA LLC | $232.26 | 2024-2025 | |
| Centrix INC | $97.85 | 2019 | |
| Ultradent Products INC | $61.99 | 2021 | |
| Sonendo INC | $47.67 | 2019 | |
| Nobel Biocare USA | $36.41 | 2023 | Nobelactive |
| Kerr Corporation | $22.46 | 2023 | Nexus Rmgi |
| Patterson Companies, INC. | $20.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrie Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.